The trial was designed to compare effectiveness and safety of surgeries in the patients with non-small cell lung cancer

The trial is a multi-centre, real-world, non-interventional, observational study. The Chinese elderly pathologically diagnosed patients with early-stage non-small cell lung cancer enrolled from 2015 to 2017 who received lobectomy or segment/wedge dissection were included and the study data on patient demographic/tumor biological characteristics, and clinical treatments were retrospectively collected to evaluate effectiveness and safety of the surgeries.

Inclusion Criteria:

• Patients who received surgeries from 2014 to 2017;
• Patients who received lobectomy or segment/wedge dissection;
• Pathologically diagnosed patients with non-small cell lung cancer;
• Patients with age >=65 years old.

Exclusion Criteria:

• Patients who received neoadjuvant therapy prior to surgery.

Pathological diagnosed elderly Chinese patients with non-small cell lung cancer who received lobectomy or segment/wedge dissection